UMC [UNITED MICROELECTRONICS] 6-K: (Original Filing)

[UNITED MICROELECTRONICS CORPORATION AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2012 AND 2011 Address: No. 3 Li-Hsin Road II, Hsinchu Science Park, Hsinchu City, Taiwan, R.O.C. Telephone: 886-3-578-2258 The reader is advised that these consolidated financial statements have been prepared originally in Chinese. In the event of a conflict between these financial statements and the] [FORM 6-K November 5, 2012 United Microelectronics Corporation ——————————————————————————————————— No. 3 Li Hsin Road II ——————————————————————————————————— x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer 6-K 1 umcfs3q12_6k.htm CONSOLIDATED FINANCIAL STATEMENTS 3Q12]

By | 2016-03-23T16:26:59+00:00 November 9th, 2012|Categories: Chinese Stocks, SEC Original, UMC|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] PRE 14A: (Original Filing)

[SCHEDULE 14A INFORMATION o Check the appropriate box: Preliminary Proxy Statement o o Definitive Proxy Statement o Definitiveditional Materials o CHINA PHARMAS, . Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction]

By | 2016-02-07T21:55:52+00:00 November 9th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

SSW [Seaspan] 6-K: (Original Filing)

[Item 1 — Information Contained in this Form 6-K Report SEASPAN CORPORATION Sai W. Chu Chief Financial Officer SEASPAN CORPORATION REPORT ON FORM 6-K FOR THE QUARTER ENDED SEPTEMBER 30, 2012 PART I — FINANCIAL INFORMATION 1 Item 1 — Interim Consolidated Financial Statements (Unaudited) 1 Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations]

By | 2016-03-10T14:47:41+00:00 November 9th, 2012|Categories: Chinese Stocks, SEC Original, SSW|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[FOR RELEASE November 8, 2012 China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2012 3Q12 Total Sales Up 28.6% to $53.1 Million BEIJING, China – November 8, 2012 – Third Quarter 2012 Financial Highlights Total sales Gross profit Income from operations Net income attributable to the Company Non-GAAP adjusted net income attributable to the] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): November 8, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6698-3166 (Former name or former address,]

SFUN [SouFun] CORRESP: (Original Filing)

[November 8, 2012 VIA EDGAR Division of Corporation Finance 100 F Street, N.E. Attention: Barbara C. Jacobs, Esq. RE: SouFun Holdings Limited Ladies and Gentlemen: Company Staff Commission 20-F On behalf of SouFun Holdings Limited (the “ The Company’s responses to the Staff’s comments are as follows (the numbered paragraphs below correspond to the numbered paragraphs of the Staff’s comment]

SFUN [SouFun] 20-F/A: (Original Filing)

[] [PURCHASE AND SALE AGREEMENT Between SAHN EAGLE LLC, a Delaware limited liability company, as SELLER, and WALL STREET GLOBAL TRAINING CENTER, INC., a New York not-for-profit corporation as PURCHASER Property: Unit 1 72 Wall Street Condominium 73 Pine Street New York, New York TABLE OF CONTENTS Page 1. DEFINITIONS 4 2. PURCHASE AND SALE 7 3. ACCESS 7 4. PURCHASE] [Assignment and Assumption of Purchase and Sale Agreement Purchase and Sale Agreement Wall Street Global Training Center, Inc., as Assignor, hereby assigns all of its right, title and interest in and to that certain purchase and sale agreement dated as of October 4, 2011 by and between Sahn Eagle LLC, a Delaware limited liability company, as Seller, and Assignor, as] [CERTIFICATION I, Richard Jiangong Dai, certify that: 1. I have reviewed this annual report on Form 20-F/A of SouFun Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Lanying Guan, certify that: 1. I have reviewed this annual report on Form 20-F/A of SouFun Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION REQUIRED BY RULE 13a-14(b) OR RULE 15d-14(b) AND 18 U.S.C. SECTION 1350 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Richard Jiangong Dai Chief Executive Officer EX-13.1 6 d435323dex131.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER REQUIRED BY RULE 13A-14(B)] [CERTIFICATION REQUIRED BY RULE 13a-14(b) OR RULE 15d-14(b) AND 18 U.S.C. SECTION 1350 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Lanying Guan Chief Financial Officer EX-13.2 7 d435323dex132.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER REQUIRED BY RULE 13A-14(B)]

CBPO [China Biologic Products] 10-Q: (Original Filing)

[FORM 10 - Q (Mark One) [ X ] For the quarterly period ended: September 30, 2012 [ ] For the transition period from _____________to ______________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial Officer)]

ONP [Orient Paper] 10-Q: (Original Filing)

[] [I, Zhenyong Liu certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Winston C. Yen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhenyong Liu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Winston C. Yen Chief Financial Officer (principal financial and accounting officer)]

GSOL [GLOBAL SOURCES] 6-K: (Original Filing)

[Press Contact in Asia Investor Contact in Asia Camellia So Suzanne Wang Tel: (852) 2555-5021 Tel: (852) 2555-4747 cso@globalsources.com e-mail: investor@globalsources.com e-mail: Press Contact in U.S. Investor Contact in U.S. Brendon Ouimette Cathy Mattison Tel: (1-480) 664-8309 LHA bouimette@globalsources.com e-mail: Tel: (1-415) 433-3777 cmattison@lhai.com e-mail: China Sourcing Fairs Contract renewal with AsiaWorld-Expo to continue hosting in Hong Kong through 2016]

By | 2016-03-07T17:35:07+00:00 November 8th, 2012|Categories: Chinese Stocks, GSOL, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar